Palantir stock jumps +12% on report of new FDA contract

Dec. 07, 2020 11:14 AM ETPalantir Technologies Inc. (PLTR)PLTRBy: Kim Khan, SA News Editor166 Comments
  • Palantir Technologies (PLTR, +12%) is rallying in morning trading after it reportedly inks a 3-year contract with the FDA.
  • The contract, to power drug review and inspections, is worth $44.4M, Bloomberg says.
  • Newly-public Palantir shares have been easing after a strong

Recommended For You

Comments (166)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.